CareDx (CDNA) Income from Continuing Operations (2013 - 2026)
CareDx (CDNA) posted Income from Continuing Operations of 110618000.0 for Q2 2026, up 3837.97% sequentially from 2809012.0 in Q1 2026, and up 1391.06% YoY from 7418750.29 in Q2 2025.
CareDx (CDNA) Income from Continuing Operations (2013 - 2026) Analysis & Trends
CareDx has reported Income from Continuing Operations for 14 years, with the latest figure at 110618000.0 in Q2 2026.
- Quarterly Income from Continuing Operations rose 1391.06% year-over-year to 110618000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 110994012.0 (up 91.05% YoY) and the FY2025 annual result came in at 21354000.0, down 140.64% from the prior year.
- Income from Continuing Operations grew to 110618000.0 in Q2 2026 per CDNA's latest filing, from 2809012.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 110618000.0 in Q2 2026 and troughed at 118097000.0 in Q4 2023.
- A 5-year average of 6796277.11 and a median of 13804500.0 in 2022 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2022 and 2026: Income from Continuing Operations slumped 2922.77% in 2022, then surged 1391.06% in 2026.
- Over 5 years, Income from Continuing Operations stood at 18329000.0 in 2022, then sank by 544.32% to 118097000.0 in 2023, then surged by 174.26% to 87697000.0 in 2024, then slumped by 104.68% to 4108000.0 in 2025, then jumped by 2792.75% to 110618000.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 110618000.0, 2809012.0, and 4108000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -66.93 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 241.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 338.41 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 232.90 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 299.10 Mn |
| 10 | CareDx | 2.69 Bn | 2.31 Bn | 116.03 Mn | 110.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 110.62 Mn |
| Mar 31, 2026 | 2.81 Mn |
| Dec 31, 2025 | -4.11 Mn |
| Sep 30, 2025 | 1.68 Mn |
| Jun 30, 2025 | -8.57 Mn |
| Mar 31, 2025 | -10.40 Mn |
| Dec 31, 2024 | 87.70 Mn |
| Sep 30, 2024 | -10.64 Mn |
| Jun 30, 2024 | -4.62 Mn |
| Mar 31, 2024 | -19.87 Mn |
| Dec 31, 2023 | -118.10 Mn |
| Sep 30, 2023 | -23.49 Mn |
| Jun 30, 2023 | -24.95 Mn |
| Mar 31, 2023 | -23.75 Mn |
| Dec 31, 2022 | -18.33 Mn |
| Sep 30, 2022 | -16.97 Mn |
| Jun 30, 2022 | -21.70 Mn |
| Mar 31, 2022 | -19.65 Mn |
| Dec 31, 2021 | -16.15 Mn |
| Sep 30, 2021 | -11.86 Mn |